Name of License: Intent to Grant an Exclusive License for U.S. Government Co-Owned Invention
Summary: In accordance with applicable laws and regulations, announcement is made of the intent to grant an exclusive, royalty-bearing, revocable, license within a field of use.
Tech Name:
Dimethyl Trisulfide As a Cyanide Antidote
Address: Commander, U.S. Army Medical Research and Development Command, ATTN: Director, Office of Research and Technology Applications, 1520 Freedman Drive, Suite 227, Fort Detrick, MD 21702-5012.
For Further Information Contact: In accordance with 35 U.S.C. 209 (e) and 37 CFR 404.7 (a)(1)(i), announcement is made of the intent to grant an exclusive within a field of use, royalty-bearing, revocable license agreement to U.S. Patent 9,375,407 issued on June 28, 2016 entitled “Dimethyl Trisulfide As a Cyanide Antidote” (co-owned by Sam Houston State University) to Defender Pharmaceuticals, having its principal place of business at 12935 North Outer Forty Road, Suite 212, St. Louis, Missouri 63141. Anyone wishing to object to grant of this option can file written objections along with supporting evidence, if any, within 15 days from the date of this publication. Written objections are to be filed with the Director, Office of Research and Technology Applications (see ADDRESSES).